MedPath

广东逢春制药有限公司

Ownership
-
Established
2006-03-20
Employees
-
Market Cap
-
Website
http://www.gdfengchun.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

58

NMPA:58

Drug Approvals

十全大补膏

Approval Number
国药准字Z44020642
Approval Date
Mar 25, 2021
NMPA

维C银翘片

Approval Number
国药准字Z20063817
Approval Date
Mar 4, 2021
NMPA

大黄䗪虫丸

Approval Number
国药准字Z20063787
Approval Date
Mar 4, 2021
NMPA

大黄䗪虫丸

Approval Number
国药准字Z20054254
Approval Date
Mar 4, 2021
NMPA

保和丸

Approval Number
国药准字Z44020683
Approval Date
Dec 2, 2019
NMPA

Norfloxacin Capsules

Product Name
诺氟沙星胶囊
Approval Number
国药准字H44021130
Approval Date
Dec 2, 2019
NMPA

壮腰健肾丸

Approval Number
国药准字Z44023741
Approval Date
Nov 19, 2019
NMPA

大活络丸

Approval Number
国药准字Z44023208
Approval Date
Nov 19, 2019
NMPA

六味地黄丸

Approval Number
国药准字Z44023214
Approval Date
Nov 19, 2019
NMPA

天麻丸

Approval Number
国药准字Z44020689
Approval Date
Nov 19, 2019
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.